Ameritas Investment Partners, Inc. Oric Pharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 6,032 shares of ORIC stock, worth $48,678. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,032
Previous 6,032
-0.0%
Holding current value
$48,678
Previous $42,000
45.24%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$42.7 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$39 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$35.5 Million4.67% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$33.4 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$32.3 Million0.16% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $319M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...